Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006502964-A |
titleOfInvention |
Methods and compositions for targeting a systemic immune response against a specific organ or tissue |
abstract |
The present invention relates to the use of one or more agents that are directed against a tissue or organ or one or more agents that are specifically placed in a desired organ or tissue, for example, for a particular organ or tissue, such as cancer. Methods and compositions are provided that target individually generated eye sleep responses to an affected organ or tissue. For example, the present invention provides methods and compositions for treating liver metastases from colorectal cancer using a combination of granulocyte-macrophage colony stimulating factor (GM-CSF) enhanced tumor cell vaccination and Listeria monocytogenes (LM) infection. I will provide a. |
priorityDate |
2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |